AstraZeneca PLC (AZNCF)
146.25
+1.15
(+0.79%)
USD |
OTCM |
Apr 29, 16:00
AstraZeneca Price: 146.25 for April 29, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 29, 2024 | 146.25 | 152.66 | 146.25 | 146.25 | 16580.00 |
| Apr 26, 2024 | 148.32 | 150.78 | 142.65 | 145.10 | 55915.00 |
| Apr 25, 2024 | 150.85 | 150.85 | 146.05 | 146.05 | 9266.00 |
| Apr 24, 2024 | 135.35 | 135.35 | 135.35 | 135.35 | 401.00 |
| Apr 23, 2024 | 140.06 | 143.40 | 139.50 | 140.30 | 1510.00 |
| Apr 22, 2024 | 138.25 | 140.47 | 136.35 | 138.73 | 3657.00 |
| Apr 19, 2024 | 135.62 | 136.20 | 133.20 | 136.20 | 1730.00 |
| Apr 18, 2024 | 138.06 | 138.24 | 133.20 | 138.24 | 797.00 |
| Apr 17, 2024 | 140.15 | 140.15 | 140.15 | 140.15 | 559.00 |
| Apr 16, 2024 | 138.80 | 138.80 | 135.30 | 135.30 | 1139.00 |
| Apr 15, 2024 | 137.20 | 137.20 | 135.94 | 135.94 | 765.00 |
| Apr 12, 2024 | 136.75 | 138.88 | 136.32 | 138.88 | 962.00 |
| Apr 11, 2024 | 138.25 | 139.85 | 136.50 | 136.50 | 1669.00 |
| Apr 10, 2024 | 134.20 | 136.25 | 134.20 | 136.25 | 701.00 |
| Apr 09, 2024 | 133.91 | 137.10 | 133.91 | 134.76 | 1281.00 |
| Apr 08, 2024 | 128.65 | 136.64 | 128.65 | 136.64 | 1461.00 |
| Apr 05, 2024 | 133.40 | 133.40 | 133.22 | 133.22 | 1097.00 |
| Apr 04, 2024 | 136.00 | 137.35 | 136.00 | 137.35 | 680.00 |
| Apr 03, 2024 | 134.64 | 134.64 | 129.71 | 131.76 | 1469.00 |
| Apr 02, 2024 | 131.66 | 131.66 | 131.66 | 131.66 | 572.00 |
| Apr 01, 2024 | 129.54 | 135.84 | 129.54 | 135.80 | 1496.00 |
| Mar 28, 2024 | 135.90 | 136.96 | 133.98 | 136.96 | 2850.00 |
| Mar 27, 2024 | 133.00 | 135.08 | 133.00 | 134.70 | 2917.00 |
| Mar 26, 2024 | 130.25 | 130.55 | 129.50 | 130.55 | 2378.00 |
| Mar 25, 2024 | 133.36 | 133.42 | 133.22 | 133.22 | 1361.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
72.75
Minimum
May 31 2019
153.10
Maximum
Apr 24 2023
115.52
Average
115.68
Median
Jun 18 2021
Price Benchmarks
| GSK PLC | 41.61 |
| Adaptimmune Therapeutics PLC | 1.15 |
| Biodexa Pharmaceuticals Plc | 1.31 |
| Verona Pharma PLC | 15.56 |
Price Related Metrics
| PE Ratio | 35.93 |
| PS Ratio | 4.798 |
| PEG Ratio | 1.034 |
| Price to Book Value | 6.055 |
| Price to Free Cash Flow | 39.49 |
| Earnings Yield | 2.78% |
| Market Cap | 226.72B |
| PEGY Ratio | 0.978 |
| Operating PE Ratio | 23.97 |
| Normalized PE Ratio | 32.89 |